Monoclonal antibody BTT1023 targeting vascular adhesion protein 1 for treating primary sclerosing cholangitis: BUTEO single-arm Phase II trial

Arndtz K, Chen Y-Y, Rowe A, Homer V, Kirkham A, Douglas-Pugh J, Slade D, Thorburn D, Barnes E, Aithal G, Newsome P, Smith D, Adams D, Weston C, Hirschfield G
Record ID 32015000703
English
Original Title: Targeting vascular adhesion protein-1 (VAP-1) for the treatment of liver fibrosis: a study of efficacy and mechanisms in patients with primary sclerosing cholangitis (PSC)
Details
Project Status: Completed
Year Published: 2022
Requestor: NIHR Health Technology Assessment programme
English language abstract: An English language summary is available
Publication Type: Full HTA
Country: England, United Kingdom
MeSH Terms
  • Cell Adhesion Molecules
  • Biomarkers
  • Liver Cirrhosis
  • Fibrosis
  • Cholangitis, Sclerosing
Contact
Organisation Name: NIHR Health Technology Assessment programme
Contact Address: NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name: journals.library@nihr.ac.uk
Contact Email: journals.library@nihr.ac.uk
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.